ArticleJournal of neuro-oncology2019

Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016.

Roberta Rudà et al.PubMed ↗Publisher ↗

No numbers read from the abstract.